| 121.4 1.07 (0.89%) | 12-12 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 146.79 | 1-year : | 171.45 |
| Resists | First : | 125.68 | Second : | 146.79 |
| Pivot price | 119.09 |
|||
| Supports | First : | 118.44 | Second : | 113.97 |
| MAs | MA(5) : | 118.84 |
MA(20) : | 118.61  |
| MA(100) : | 128.9 |
MA(250) : | 0 | |
| MACD | MACD : | -1 |
Signal : | -1.5 |
| %K %D | K(14,3) : | 70.7 |
D(3) : | 55.9 |
| RSI | RSI(14): 54 |
|||
| 52-week | High : | 179.6 | Low : | 113.97 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ DVA ] has closed below upper band by 10.3%. Bollinger Bands are 52.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 121.93 - 122.42 | 122.42 - 122.93 |
| Low: | 119.46 - 119.98 | 119.98 - 120.51 |
| Close: | 120.56 - 121.45 | 121.45 - 122.37 |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Sat, 13 Dec 2025
Berkshire Hathaway Inc Sells 1,345,938 Shares of DaVita Inc. $DVA - MarketBeat
Thu, 11 Dec 2025
Do DaVita’s New Strategy and People Chiefs Subtly Recast Its Long‑Term Story (DVA)? - Yahoo Finance
Thu, 11 Dec 2025
DaVita Names New Leaders to Accelerate Care Transformation - PR Newswire
Wed, 10 Dec 2025
DaVita Inc. $DVA Shares Purchased by Jump Financial LLC - MarketBeat
Mon, 08 Dec 2025
Norges Bank Makes New Investment in DaVita Inc. $DVA - MarketBeat
Wed, 03 Dec 2025
DaVita - More Volatile But Better Upside Than Fresenius (NYSE:DVA) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 71 (M) |
| Shares Float | 37 (M) |
| Held by Insiders | 50 (%) |
| Held by Institutions | 51.3 (%) |
| Shares Short | 7,280 (K) |
| Shares Short P.Month | 6,520 (K) |
| EPS | 9.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -8.07 |
| Profit Margin | 5.8 % |
| Operating Margin | 14.8 % |
| Return on Assets (ttm) | 7 % |
| Return on Equity (ttm) | 61.6 % |
| Qtrly Rev. Growth | 4.8 % |
| Gross Profit (p.s.) | 60.33 |
| Sales Per Share | 188.66 |
| EBITDA (p.s.) | 37.81 |
| Qtrly Earnings Growth | -18.4 % |
| Operating Cash Flow | 1,890 (M) |
| Levered Free Cash Flow | 957 (M) |
| PE Ratio | 12.52 |
| PEG Ratio | 0 |
| Price to Book value | -15.07 |
| Price to Sales | 0.64 |
| Price to Cash Flow | 4.53 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|